IMUNOMODULADORES - DARATUMUMAB - 3 MESES
Buyer: Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM)
- Published
- 2 October 2026
- Estimated value
- €458,281
- Place of performance
- PT300
- Procedure
- Restricted procedure
- Lots
- 1
- Notice number
- 00679613-2026
- Reference
- bd6c0883-c9db-428f-ac27-b6ded374d1a8
- Official source
- Official source
CPV codes
- 33690000Various medicinal products
Description
IMUNOMODULADORES - DARATUMUMAB - 3 MESES
Award criteria
- Price — 100%
Awards
| Awarded to | Amount | Date |
|---|---|---|
| JANSSEN CILAG FARMACEUTICA, LDA | €458,281 | — |
Official publications
- TED · 00679613-2026 · 2 October 2026
- OJS · 191/2026 · 2 October 2026
Other tenders from Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM)
- ANTIVIRICOS - 3 MESES
- VACINAS - AGREGAÇÃO CENTRALIZADA PNV
- IMUNOMODULADORES - PEMBROLIZUMAB - 2 MESES
- IMUNOMODULADORES - NIVOLUMAB - 3 MESES
- VACINAS AGREGAÇÃO CENTRALIZADA ÉPOCA GRIPAL 2026/2027
- IMUNOGLOBULINAS E SOROS - 3 MESES
- ANTIVIRICOS-BICTEGRAVIR+EMTRICITABINA + TENOFOVIR ALAFENAMIDA - 3MESES
- INIBIDORES DE TIROSINACINASES - OSIMERTINIB - 3 MESES
- ANTIASMATICOS - MEPOLIZUMAB - 3 MESES
- CARDIOVERSORES DESFIBRILHADORES
Frequently asked questions
- What is the estimated value of this tender?
- The estimated value published by the buyer is €458,281.
- Who is the buyer of this tender?
- The contracting authority is Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM) (European Union).
- How can I bid for public tenders in the European Union?
- Bids are submitted through the official public procurement portal in the European Union. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Get alerts for tenders like this
Create a free account and receive new public tenders published in the European Union that match your business, every day.
Create a free account and receive new public tenders published in the European Union that match your business, every day.